COMPANY
ALP PHARM BEIJING CO LTD
ALP PHARM BEIJING CO LTD: API manufacturer for Bacitracin, Cetrorelix, Difelikefalin, Exenatide, Goserelin, Lanreotide, Leuprolide, Liraglutide, Octreotide, Plecanatide, Semaglutide, Teduglutide, Tirzepatide, as stated by public registers.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Bacitracin | DMF 23999, type II, active, submitted 2010-07-02 Regulator FDA drug master file list |
|---|---|
| Bacitracin | DMF 24000, type II, active, submitted 2010-07-02 Regulator FDA drug master file list |
| Cetrorelix | DMF 33914, type II, active, submitted 2019-06-05 Regulator FDA drug master file list |
| Difelikefalin | DMF 38645, type II, active, submitted 2023-08-02 Regulator FDA drug master file list |
| Exenatide | DMF 35476, type II, active, submitted 2020-12-15 Regulator FDA drug master file list |
| Goserelin | DMF 29713, type II, active, submitted 2015-09-10 Regulator FDA drug master file list |
| Lanreotide | DMF 24378, type II, active, submitted 2010-11-05 Regulator FDA drug master file list |
| Leuprolide | DMF 34847, type II, active, submitted 2020-04-28 Regulator FDA drug master file list |
| Liraglutide | DMF 29711, type II, active, submitted 2015-09-10 Regulator FDA drug master file list |
| Octreotide | DMF 30992, type II, active, submitted 2016-10-26 Regulator FDA drug master file list |
| Plecanatide | DMF 35439, type II, active, submitted 2020-12-08 Regulator FDA drug master file list |
| Semaglutide | DMF 35875, type II, active, submitted 2021-04-22 Regulator FDA drug master file list |
| Teduglutide | DMF 35438, type II, active, submitted 2020-12-08 Regulator FDA drug master file list |
| Tirzepatide | DMF 38773, type II, active, submitted 2023-08-30 Regulator FDA drug master file list |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.